Impact Biomedical IBO
NYSE IBO
$0.48 +0.03 (+6.83%)
As of: Aug 21, 2026 · 2:19 PM EDT

Impact Biomedical (IBO) Property, Plant & Equipment (Net) (2022 - 2025)

Impact Biomedical (IBO) Property, Plant & Equipment (Net) (2022 - 2025) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Property, Plant & Equipment (Net) (Qtr)
1 Vertex Pharmaceuticals 139.13 Bn 131.28 Bn 2.84 Bn 1.67 Bn
2 Regeneron Pharmaceuticals 85.77 Bn 77.77 Bn 3.93 Bn 5.46 Bn
3 Argenx Se 64.64 Bn 59.46 Bn 1.37 Bn 1.96 Bn
4 Moderna 58.29 Bn 53.16 Bn 52.00 Mn 2.06 Bn
5 BeOne Medicines 41.92 Bn 36.82 Bn 1.53 Bn 1.64 Bn
6 Alnylam Pharmaceuticals 31.58 Bn 28.28 Bn 992.69 Mn 554.14 Mn
7 BioNTech SE 28.12 Bn 9.73 Bn 668.28 Mn 6.80 Bn
8 Insmed 27.39 Bn 26.22 Bn 358.27 Mn 107.22 Mn
9 Royalty Pharma 27.27 Bn 26.43 Bn - -
10 Impact Biomedical 49.54 Mn 49.53 Mn 2,000.00 -

Historic Data

Download Data
DateValue
Sep 30, 2025 13,000.00
Sep 30, 2025 13,000.00
Jun 30, 2025 14,000.00
Jun 30, 2025 14,000.00
Mar 31, 2025 16,000.00
Mar 31, 2025 16,000.00
Dec 31, 2024 17,000.00
Dec 31, 2024 17,000.00
Sep 30, 2024 282,000.00
Sep 30, 2024 282,000.00
Jun 30, 2024 284,000.00
Jun 30, 2024 284,000.00
Mar 31, 2024 285,000.00
Mar 31, 2024 285,000.00
Dec 31, 2023 287,000.00
Dec 31, 2023 287,000.00
Sep 30, 2023 289,000.00
Sep 30, 2023 289,000.00
Jun 30, 2023 290,000.00
Jun 30, 2023 290,000.00